Stay updated on Lanadelumab Long-Term Safety & Efficacy in Angioedema Clinical Trial
Sign up to get notified when there's something new on the Lanadelumab Long-Term Safety & Efficacy in Angioedema Clinical Trial page.

Latest updates to the Lanadelumab Long-Term Safety & Efficacy in Angioedema Clinical Trial page
- Check4 days agoChange DetectedRevision v3.4.3 was added and Revision v3.4.2 was removed from the history.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedA new version entry 'Revision: v3.4.2' was added to the Study Record Versions. Notices about government funding lapse and the older 'Revision: v3.4.1' were removed.SummaryDifference0.7%

- Check39 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and that the NIH Clinical Center is open, and updated the history page version from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check46 days agoChange DetectedUI changes include a new 'Show glossary' toggle, color-coded highlights for additions (green) and deletions (red), and an updated revision label (v3.4.0) with a 'No FEAR Act Data' note, which are presentation changes and do not modify the underlying study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1.0%

- Check60 days agoChange DetectedThe history now includes a new revision entry, v3.3.4, and removes v3.3.3, updating the record history accordingly.SummaryDifference0.1%

- Check82 days agoChange DetectedAdded Revision: v3.3.3 to the page history. Removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the footer.SummaryDifference0.2%

Stay in the know with updates to Lanadelumab Long-Term Safety & Efficacy in Angioedema Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lanadelumab Long-Term Safety & Efficacy in Angioedema Clinical Trial page.